Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

The RV144 prime-boost regimen demonstrated efficacy against HIV acquisition while VAX003 and VAX004 did not. Although these trials differed by risk groups, immunization regimens, and immunogens, antibody responses may have contributed to the differences observed in vaccine efficacy. We assessed HIV-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Res Hum Retroviruses
Main Authors: Karnasuta, Chitraporn, Akapirat, Siriwat, Madnote, Sirinan, Savadsuk, Hathairat, Puangkaew, Jiraporn, Rittiroongrad, Surawach, Rerks-Ngarm, Supachai, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Kaewkungwal, Jaranit, Tartaglia, James, Sinangil, Faruk, Francis, Donald P., Robb, Merlin L., de Souza, Mark S., Michael, Nelson L., Excler, Jean-Louis, Kim, Jerome H., O'Connell, Robert J., Karasavvas, Nicos
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2017
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5439458/
https://ncbi.nlm.nih.gov/pubmed/28006952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2016.0204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados